Treatment of Angioedema Attacks in Adolescent and Adult Patients 12 Years and Older With HAE Type I or II With Sebetralstat

NCT06628713 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema

Interventions

DRUG: Sebetralstat

Sponsor

KalVista Pharmaceuticals, Ltd.